About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Scientists Develop a Better Tool for Tracking Multiple Sclerosis

by Bidita Debnath on May 28, 2014 at 10:41 PM
Font : A-A+

 Scientists Develop a Better Tool for Tracking Multiple Sclerosis

At Western University's Robarts Research Institute (London, Canada), imaging scientists have developed a better way to track the progression of Multiple Sclerosis (MS) from its earliest stages.

Led by Ravi Menon, PhD, the researchers used what's called "Quantitative Susceptibility (QS) Magnetic Resonance Imaging (MRI)," to measure damage in specific areas of the brain which the study showed to be common to all patients. The findings are published in advance online, in Radiology.

Advertisement

"In MS research, there is something we call a clinical-radiological paradox. When you do conventional MRIs on these patients you see lesions in the brain very clearly, but the number or volume of their lesions do not correlate with the patients' disabilities. This paradox has been recognized since the MRI was introduced to clinical practice in the early 80s, and yet this is the only imaging tool we have for assessing MS," says Menon. "Our research provides a quantitative tool using a relatively conventional imaging sequence but with novel analysis. This tool shows that there is considerable damage occurring in common areas of all patients in both the white matter and in the deep brain structures -the gray matter. Those quantitative measures -what we call quantitative susceptibility, correlate with disease symptoms."

The process used a standard Siemens 3T MRI so it could be reproduced in any hospital, using the technique, called QS. The researchers mapped this MRI parameter in 25 patients with relapsing-remitting MS or clinically isolated syndrome (CIS -half of those diagnosed with CIS will go on to be diagnosed with MS) measuring both demyelination and iron deposition. Fifteen age and sex-matched control subjects were also scanned. While brain and spine lesions visualized with normal MRI tend to appear and disappear over time, QS shows common areas of damage in all patients that correlated very well with the Extended Disability Status Score (EDSS) which is a standard tool used to measure MS progression, as well as with age and time since diagnosis.
Advertisement

"Significantly, in white matter, even where we see no lesions whatsoever, we're able to measure damage in the same area of all patients using QS mapping. So even at the very earliest stages of the disease when the disability score is very low, or when the person hasn't yet been diagnosed with MS, there's already significant damage," adds Menon. This could have important diagnostic and prognostic implications, as there are drugs available to slow or stop the progression of MS, if started early enough.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sensory Processing Disorder (SPD)
First Dose of COVID-19 Vaccines May Improve Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Chemotherapy Chemotherapy Drugs Infectious Mononucleosis Multiple Sclerosis Treatment and Modify Autoimmune Disorders 

Recommended Reading
Preliminary Results of a Clinical Study Shows Improvement in Multiple Sclerosis Symptoms
Combining the estrogen hormone estriol with Copaxone, a drug indicated for the treatment of ......
Review of Current Treatment of Multiple Sclerosis: For Physicians
Evidence-based information for the physicians on the latest treatments for multiple sclerosis is ......
New Version of Old Multiple Sclerosis Drug Worked Better in Clinical Trial
Researchers report that tests of a new long-acting version of one of the oldest multiple sclerosis ....
Underlying Action of New Multiple Sclerosis Drug Decoded
The new drug, dimethyl fumarate has recently been approved in Europe as a basic therapy for ......
Autoimmune Disorders
Autoimmune disorders occur when the immune system fails to recognize the body as ‘self’ and attacks ...
Chemotherapy
‘Chemo’ means medicine or ‘drug’; ‘therapy’ means ‘treatment’. Chemotherapy refers to the use of cy...
Chemotherapy Drugs
Chemotherapy drugs perform like ‘magic bullets’ to destroy cancer cells in the body....
Infectious Mononucleosis
Called also the kissing diesase, Mononucleosis is an infectious disease due to infection with the Ep...
Multiple Sclerosis Treatment and Modify
Multiple sclerosis is treated with drugs that modify the course of the disease, suppress immunity an...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use